Simile Raises $200 Million Series B at $2 Billion Valuation

July 30, 2026
Simile raised a $200 million Series B led by Greenoaks Capital at a $2 billion valuation to expand its human behavior simulation platform.

Simile raised a $200 million Series B at a $2 billion valuation. The round was led by Greenoaks Capital, with participation from Index Ventures, Hanabi Capital, Bain Capital Ventures, A*, Factory, CVS Health Ventures, and new investor Definition.

The company said the funding will support development of its foundation model for human behavior and help scale its simulation platform. The round follows a $100 million Series A led by Index Ventures five months ago, when Simile emerged from stealth.

Organizations including CVS Health and Wealthfront are using Simile to simulate human behavior and test decisions before using them in live settings. CVS Health has used the platform for customer research validation, patient satisfaction analysis, medication adherence planning, competitive benchmarking, and modeling patient groups that are hard to reach.

Simile is also working with Gallup on AI powered simulations for policy research, trend analysis, workplace studies, and social research. The company was founded by CEO Joon Sung Park.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Enterprise AI Brief

Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more